Department of Radiology

Publications

2015

Weisholtz DS, Root JC, Butler T, Tüscher O, Epstein J, Pan H, et al. Beyond the amygdala: Linguistic threat modulates peri-sylvian semantic access cortices. Brain Lang. 2015;151:12-22.

Kuceyeski A, Navi BB, Kamel H, Relkin N, Villanueva M, Raj A, et al. Exploring the brain's structural connectome: A quantitative stroke lesion-dysfunction mapping study. Hum Brain Mapp. 2015;36(6):2147-60.

Ni W, Christen T, Zun Z, Zaharchuk G. Comparison of R2' measurement methods in the normal brain at 3 Tesla. Magn Reson Med. 2015;73(3):1228-36.

Weiduschat N, Mao X, M Beal F, Nirenberg MJ, Shungu DC, Henchcliffe C. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease. J Neuroimaging. 2015;25(1):105-10.

Zhang J, Liu T, Gupta A, Spincemaille P, Nguyen TD, Wang Y. Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using quantitative susceptibility mapping (QSM). Magn Reson Med. 2015;74(4):945-52.

Leftin A, Rosenberg JT, Solomon E, Bejarano FC, Grant SC, Frydman L. Ultrafast in vivo diffusion imaging of stroke at 21.1 T by spatiotemporal encoding. Magn Reson Med. 2015;73(4):1483-9.

Dong J, Liu T, Chen F, Zhou D, Dimov A, Raj A, et al. Simultaneous phase unwrapping and removal of chemical shift (SPURS) using graph cuts: application in quantitative susceptibility mapping. IEEE Trans Med Imaging. 2015;34(2):531-40.

Yang D, Mosadegh B, Ainla A, Lee B, Khashai F, Suo Z, et al. Buckling of Elastomeric Beams Enables Actuation of Soft Machines. Adv Mater. 2015;27(41):6323-7.

Dyke JP, Synan M, Ezell P, Ballon D, Racine J, Aaron RK. Characterization of bone perfusion by dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography in the Dunkin-Hartley guinea pig model of advanced osteoarthritis. J Orthop Res. 2015;33(3):366-72.

Pandit-Taskar N, O'Donoghue JA, Durack JC, Lyashchenko SK, Cheal SM, Beylergil V, et al. A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer. Clin Cancer Res. 2015;21(23):5277-85.